Article
Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease.
Genes - 6 Jul 2024
Kamali Zoha, Esmaeil Nafiseh, Thio Chris H L, Vaez Ahmad, Snieder Harold
Abstract excerpt
OBJECTIVES: Interleukin 6 (IL-6) levels at hospital admission have been suggested for disease prognosis, and IL-6 antagonists have been suggested for the treatment of patients with severe COVID-19. However, less is known about the relationship between pre-COVID-19 IL-6 levels and the risk of severe COVID-19. To fill in this gap, here we extensively investigated the association of genetically instrumented IL-6...
Topics
- Humans
- Interleukin-6
- COVID-19
- Mendelian Randomization Analysis
- Receptors, Interleukin-6
- SARS-CoV-2
- Biomarkers
- Genome-Wide Association Study
- Polymorphism, Single Nucleotide
- Signal Transduction
